| COMPOSITION: | Each film coated bilayered tablet contains Cilnidipine 10 mg, Telmisartan 40 mg & Metoprolol Tartrate 50 mg ER |
| FORMULATION: | TABLETS |
| STATUS: | PRESCRIPTION ONLY DRUG |
| DESCRIPTION: | CILNIFORD-TM tablets contain Cilnidipine, a calcium channel blocker; Telmisartan, an angiotensin II receptor blocker (ARB); and Metoprolol Tartrate (ER), a beta-blocker. This triple combination works synergistically to relax blood vessels, reduce heart rate, and lower blood pressure. It is prescribed for the effective management of moderate to severe hypertension and to reduce the risk of cardiovascular events. |
| SIDE EFFECTS: | It is generally well tolerated. The main side effects may include dizziness, fatigue, slow heart rate, swelling of ankles, headache, cold extremities, and gastrointestinal discomfort. |
| DOSAGE/DIRECTIONS FOR USE: | As Prescribed by Physician |
